Lilly registers three new early trials: olomorasib in colorectal cancer, two obesity studiesSep 11Weekly roundup, 3 itemsEli Lillyeloralintide
Vertex registers Phase 1 drug interaction study for VX-407 with oral contraceptivesAug 28Trial updateVertex Pharmaceuticals Inc / Ma
Viatris raises 2026 guidance, reports FDA approvals and Tyrvaya sale in Q2 updateAug 6Quarterly updatevareniclineViatris Inc.
Sign inSign in